These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2145067)
1. An open-label trial of milacemide in schizophrenia: an NMDA intervention strategy. Rosse RB; Schwartz BL; Leighton MP; Davis RE; Deutsch SI Clin Neuropharmacol; 1990 Aug; 13(4):348-54. PubMed ID: 2145067 [No Abstract] [Full Text] [Related]
2. An NMDA intervention strategy in schizophrenia with "low-dose" milacemide. Rosse RB; Schwartz BL; Davis RE; Deutsch SI Clin Neuropharmacol; 1991 Jun; 14(3):268-72. PubMed ID: 1829980 [TBL] [Abstract][Full Text] [Related]
3. NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia. Coyle JT; Tsai G Int Rev Neurobiol; 2004; 59():491-515. PubMed ID: 15006500 [No Abstract] [Full Text] [Related]
4. Milacemide and other drugs active at glutamate NMDA receptors as potential treatment for dementia. Herting RL Ann N Y Acad Sci; 1991; 640():237-40. PubMed ID: 1837978 [TBL] [Abstract][Full Text] [Related]
6. Glycine agonists: what can they teach us about schizophrenia? Farber NB; Newcomer JW; Olney JW Arch Gen Psychiatry; 1999 Jan; 56(1):13-7. PubMed ID: 9892251 [No Abstract] [Full Text] [Related]
7. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Goff DC; Tsai G; Levitt J; Amico E; Manoach D; Schoenfeld DA; Hayden DL; McCarley R; Coyle JT Arch Gen Psychiatry; 1999 Jan; 56(1):21-7. PubMed ID: 9892252 [TBL] [Abstract][Full Text] [Related]
8. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Coyle JT; Tsai G; Goff D Ann N Y Acad Sci; 2003 Nov; 1003():318-27. PubMed ID: 14684455 [TBL] [Abstract][Full Text] [Related]
9. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Anand A; Charney DS; Oren DA; Berman RM; Hu XS; Cappiello A; Krystal JH Arch Gen Psychiatry; 2000 Mar; 57(3):270-6. PubMed ID: 10711913 [TBL] [Abstract][Full Text] [Related]
10. [Glycine therapy of schizophrenia; its rationale and a review of clinical trials]. Semba J Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Jun; 18(3):71-80. PubMed ID: 9800198 [TBL] [Abstract][Full Text] [Related]